The Lung Cancer Policy Network has published 2024 year in review: from evidence to action, showcasing the progress we’ve made in the past year.
Our primary goal was to turn our extensive evidence on reducing lung cancer mortality – which we’ve been gathering since 2021 – into actionable policy change.
Over the past year, the Network has grown to over 80 members from 34 countries, and we have strengthened our role as a trusted voice in the lung cancer space. Our growing community has been instrumental in shaping evidence-based, consensus-driven outputs that reflect the realities of lung cancer care around the world.
Looking ahead to 2025, we are focused on extending our global reach, and leveraging our collective expertise and respected position to further advance early detection, improve lung cancer care, and drive meaningful policy impact.
We hope you will join us.
Recent news
Blog
Lung cancer: the looming economic crisis governments can’t ignore
Lung cancer carries a heavy cost – not only for the people diagnosed, but for health systems and economies alike.
Blog
Beyond lung cancer: how LDCT screening could reshape early detection
Health systems are under growing strain. The challenge is no longer simply how to treat illness, but how to detect it earlier and manage it more efficiently.
News
Insights from the I-ELCAP 3rd Annual AGILEᴰˣᴿˣ meeting
In March, the Network attended the International Early Lung Cancer Action Program 3rd Annual AGILEᴰˣᴿˣ meeting in Gdańsk, Poland.